# Battling Influenza in Elderly Patients: A Case of Severe Influenza A With Complications in a High-Risk Patient

**Authors:** Argavan Ansari, Annie Taffaro, Zachary McSween, Jenny Lu, Alice Huang, Roxana Lazarescu

PMC · DOI: 10.7759/cureus.82303 · Cureus · 2025-04-15

## TL;DR

This case report highlights the severe complications of influenza A in an elderly patient with chronic conditions and the importance of early treatment and monitoring.

## Contribution

The paper presents a detailed clinical case emphasizing management strategies for severe influenza in high-risk elderly patients.

## Key findings

- The patient developed sepsis and hypoxic respiratory failure from influenza A despite initial treatment for viral pneumonia.
- Timely ICU intervention and antibiotic therapy improved the patient's condition over seven days.
- The case highlights the need for early antiviral therapy and preventive measures in elderly populations.

## Abstract

Influenza is a significant cause of morbidity and mortality in the elderly, particularly in those with chronic comorbidities and age-related immunosenescence. This case report details an 80-year-old male with a history of hyperlipidemia, diabetes mellitus, and dementia who developed a severe influenza A infection complicated by sepsis and hypoxic respiratory failure. Upon admission, the patient presented with fever, cough, and weakness, and was initially treated for viral pneumonia. Despite negative blood and urine cultures, influenza A was confirmed via reverse transcription polymerase chain reaction (RT-PCR). The patient developed hypotension, was unresponsive to fluid resuscitation, and was transferred to the ICU for pressor support with norepinephrine and albumin.

During his intensive care unit (ICU) stay, septic shock was managed with norepinephrine, with a target mean arterial pressure (MAP) of >65 mmHg. The patient also received respiratory support, initially on a 10L high-flow nasal cannula, and was later downgraded to a 4L nasal cannula. A sacral pressure ulcer and MRSA colonization further complicated his hospital course. Antibiotic therapy included ceftriaxone, azithromycin, and vancomycin, and the patient’s condition gradually improved, allowing for transfer to the intermediate care unit (IMCU) after seven days. This case underscores the importance of early antiviral therapy, the need for vigilant monitoring for secondary infections, and timely intervention to manage complications such as sepsis in elderly patients. Enhanced vaccination coverage and preventive measures are critical for reducing the incidence of severe influenza and associated complications in at-risk populations.

## Linked entities

- **Diseases:** influenza (MONDO:0005812), hyperlipidemia (MONDO:0021187), diabetes mellitus (MONDO:0005015), dementia (MONDO:0001627)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** septic shock (MESH:D012772), bacterial pneumonia (MESH:D018410), Battling Influenza (MESH:D007251), sepsis (MESH:D018805), diabetes mellitus (MESH:D003920), cough (MESH:D003371), fever (MESH:D005334), hypoxic (MESH:D002534), diarrhea (MESH:D003967), infection (MESH:D007239), infectious disease (MESH:D003141), Pneumonia (MESH:D011014), wound infection (MESH:D014946), MRSA (MESH:D013203), inflammatory (MESH:D007249), acute respiratory failure (MESH:D012131), death (MESH:D003643), CAP (MESH:D003147), tachycardia (MESH:D013610), bacterial infections (MESH:D001424), bacterial superinfection (MESH:D015163), type 2 diabetes mellitus (MESH:D003924), malnutrition (MESH:D044342), critical illness (MESH:D016638), dementia (MESH:D003704), leukocytosis (MESH:D007964), sacral pressure injury (MESH:C537221), weakness (MESH:D018908), hyperglycemia (MESH:D006943), hyperlipidemia (MESH:D006949), toxicity (MESH:D064420), hypotension (MESH:D007022), lethargy (MESH:D053609), pulmonary infiltrate (MESH:D017254), pleural effusion (MESH:D010996), pressure injury (MESH:D003668)
- **Chemicals:** vancomycin (MESH:D014640), azithromycin (MESH:D017963), ceftriaxone (MESH:D002443), lactate (MESH:D019344), methicillin (MESH:D008712), midodrine (MESH:D008879), Norepinephrine (MESH:D009638), MF59 (MESH:C089950), carbohydrate (MESH:D002241), oxygen (MESH:D010100)
- **Species:** Homo sapiens (human, species) [taxon 9606], Streptococcus pneumoniae (species) [taxon 1313], Staphylococcus aureus (species) [taxon 1280], Legionella (genus) [taxon 445]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12080737/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12080737/full.md

## References

9 references — full list in the complete paper: https://tomesphere.com/paper/PMC12080737/full.md

---
Source: https://tomesphere.com/paper/PMC12080737